Subscribe to Newsletter
Subspecialties Refractive

The Ophthalmologist’s Time Machine: Chapter 23

| Christopher T. Leffler, David Spalton, Andrzej Grzybowski, Stephen G. Schwartz | 3 min read

Harold Ridley and the First Intraocular Lens

Business & Profession Basic & Translational Research

Also in the News…

| Alun Evans

The Ophthalmologist brings you the top news stories and studies of the week

Business & Profession Health Economics and Policy

Standpoint on Sustainability (SOS): Barbara Erny

| Jamie Irvine, Alun Evans | 4 min read

I want to see every physician prioritizing the principle, "First, do no harm", by practicing in a sustainable way, says Barbara Erny

Subspecialties Cataract

SERI and Zeiss Join Forces to Improve Vision in Singapore

| The Ophthalmologist | 3 min read

Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec announce OPTIZS initiative

Subspecialties Health Economics and Policy

Retinoblastoma Chemotherapy: Less Is More

| The Ophthalmologist | 3 min read

A recent clinical trial compares three cycles versus six cycles of CEV chemotherapy for high-risk retinoblastoma patients

Subspecialties Health Economics and Policy

“Integration” in Ghanaian Ophthalmology

| Jamie Irvine | 3 min read

Approaching the challenges of access and resources in Ghana’s health system

Subspecialties Health Economics and Policy

Beating the Refractive Blues

| The Ophthalmologist | 3 min read

How physical activity and better sleep patterns can reduce the mental health impact of visual impairment

Subspecialties Basic & Translational Research

The Ophthalmologist Power List 2025: Nominate Now!

| Julian Upton | 3 min read

The Power List celebrates the world’s most inspiring and influential ophthalmologists

Business & Profession Retina

Demystifying Retina Neuroprotection

| Allen C. Ho | 7 min read

Could emerging neuroprotective strategies represent a new era for retinal disease treatment?

Subspecialties Imaging & Diagnostics

Blood Biomarkers for AMD

| The Ophthalmologist | 3 min read

Shanghai-based researchers investigate three metabolite biomarkers for diagnosing and monitoring age-related macular degeneration

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: